Embryonic stem cells rely on Polycomb group proteins to reversibly repress genes required for differentiation. We report that stem cell Polycomb group targets are up to 12-fold more likely to have cancer-specific promoter DNA hypermethylation than non-targets, supporting a stem cell origin of cancer in which reversible gene repression is replaced by permanent silencing, locking the cell into a perpetual state of self-renewal and thereby predisposing to subsequent malignant transformation.
Epigenetic stem cell signature in cancer. Publishing Authors By Initials
Epigenetic stem cell signature in cancer. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: Nature genetics
VOLUME: 39
Page Numbers: 157-8
Journal Abbreviation: Nat. Genet.
ISSN: 1061-4036
DAY: 31
MONTH: 12
YEAR: 2006
Epigenetic stem cell signature in cancer. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9216904
Epigenetic stem cell signature in cancer. Keywords Mesh Terms:
KEYWORDS: Stem Cells
MESH TERMS: physiology
Chemical & Substance for Abstract: Epigenetic stem cell signature in cancer. Information
Substance Name: polycomb group proteins
Registry Number: 0
Grant and Affiliation Information for Epigenetic stem cell signature in cancer.
AFFILIATION: Department of Gynecological Oncology, Institute for Women's Health, University College London, London WC1E 6DH, UK. M.Widschwendter@ucl.ac.uk
Country: United States
AGENCY: United States NCI
GRANT: R01 CA075090
ACRONYM: CA
MEDLINETA: Nat Genet
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Epigenetic stem cell signature in cancer Related Publications